CURE vs. VALG
CURE (Direxion Daily Healthcare Bull 3x Shares) and VALG (Leverage Shares 2X Long VALE Daily ETF) are both Leveraged Equities funds - CURE tracks the Health Care Select Sector Index (300%) while VALG tracks the Vale S.A. (VALE). Both are passively managed. At a 0.19 correlation, their price movements are largely independent. CURE charges 1.08%/yr vs 0.75%/yr for VALG.
Performance
CURE vs. VALG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE achieves a -0.14% return, which is significantly lower than VALG's 9.11% return.
CURE
- 1D
- -5.67%
- 1M
- 8.49%
- 6M
- -3.29%
- YTD
- -0.14%
- 1Y
- 42.28%
- 3Y*
- 5.85%
- 5Y*
- 1.16%
- 10Y*
- 13.12%
VALG
- 1D
- 6.09%
- 1M
- -15.01%
- 6M
- -6.08%
- YTD
- 9.11%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CURE vs. VALG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | -0.14% | 2.81% |
VALG Leverage Shares 2X Long VALE Daily ETF | 9.11% | 1.57% |
Correlation
The correlation between CURE and VALG is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Dec 18, 2025 | 0.19 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE vs. VALG — Risk / Return Rank
CURE
VALG
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
CURE vs. VALG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Leverage Shares 2X Long VALE Daily ETF (VALG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CURE | VALG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.18 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.37 | — | — |
| Martin ratioReturn relative to average drawdown | 3.04 | — | — |
Loading charts...
Drawdowns
CURE vs. VALG - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, which is greater than VALG's maximum drawdown of -41.01%. Use the drawdown chart below to compare losses from any high point for CURE and VALG.
Loading charts...
Drawdown Indicators
| CURE | VALG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -41.01% | -28.18% |
Max Drawdown (1Y)Largest decline over 1 year | -31.10% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -51.93% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | — | — |
Current DrawdownCurrent decline from peak | -20.74% | -36.85% | +16.11% |
Average DrawdownAverage peak-to-trough decline | -18.17% | -15.47% | -2.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.95% | — | — |
Volatility
CURE vs. VALG - Volatility Comparison
Loading charts...
Volatility by Period
| CURE | VALG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.02% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 34.09% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 46.74% | 73.64% | -26.90% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.47% | 73.64% | -29.17% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.72% | 73.64% | -23.92% |
CURE vs. VALG - Expense Ratio Comparison
CURE has a 1.08% expense ratio, which is higher than VALG's 0.75% expense ratio.
Dividends
CURE vs. VALG - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.14%, while VALG has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.14% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% |
VALG Leverage Shares 2X Long VALE Daily ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
CURE and VALG have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, VALG is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.
VALG is cheaper with a 0.75% expense ratio, compared with 1.08% for CURE.
CURE has the higher dividend yield at 1.14%, compared with 0.00% for VALG.
CURE tracks Health Care Select Sector Index (300%), while VALG tracks Vale S.A. (VALE). They also come from different issuers: Direxion and Leverage Shares. Their fees differ too: 1.08% for CURE and 0.75% for VALG.
Find the right allocation for CURE and VALG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer